Inno Medicine Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Series D
- Latest Deal Amount
-
$119M
- Investors
-
35
Inno Medicine General Information
Description
Developer of diagnostic and targeted therapeutic products designed for the treatment of diseases with unmet clinical needs. The company's technology uses liposome-based active targeting, a nano-drug delivery platform, GMP-compliant manufacturing, pipeline R&D, drug product formulation, and preclinical studies to treat diseases with unmet clinical needs.
Contact Information
Website
www.innovmedicine.comCorporate Office
- Building 9, Area C, Yiyuan Cultural and Creative Industry Base, Xingshikou Road
- Haidian District
- Beijing, 100195
- China
Corporate Office
- Building 9, Area C, Yiyuan Cultural and Creative Industry Base, Xingshikou Road
- Haidian District
- Beijing, 100195
- China
Inno Medicine Timeline
Inno Medicine Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC (Series D) | 08-Sep-2026 | $119M | Completed | Generating Revenue | ||
| 10. Later Stage VC | 23-Mar-2026 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series C2) | 19-Oct-2025 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series C1) | 27-Jun-2024 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series C) | 02-Jul-2023 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Private | 16-Jan-2023 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B1) | 20-Apr-2022 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B) | 09-May-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 20-Jul-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A1) | 26-Sep-2019 | Completed | Generating Revenue |
Inno Medicine Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Inno Medicine Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Inno Medicine Investors (35)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Beijing State-owned Capital Operation and Management | Government | Minority | ||
| Chunjia Capital | PE/Buyout | Minority | ||
| Co-Stone Capital | PE/Buyout | Minority | ||
| Gaorong Ventures | Venture Capital | Minority | ||
| Northern Light Venture Capital | Venture Capital | Minority |
Inno Medicine FAQs
-
When was Inno Medicine founded?
Inno Medicine was founded in 2016.
-
Where is Inno Medicine headquartered?
Inno Medicine is headquartered in Beijing, China.
-
What is the size of Inno Medicine?
Inno Medicine has 11 total employees.
-
What industry is Inno Medicine in?
Inno Medicine’s primary industry is Drug Discovery.
-
Is Inno Medicine a private or public company?
Inno Medicine is a Private company.
-
What is Inno Medicine’s current revenue?
The current revenue for Inno Medicine is .
-
How much funding has Inno Medicine raised over time?
Inno Medicine has raised $119M.
-
Who are Inno Medicine’s investors?
Beijing State-owned Capital Operation and Management, Chunjia Capital, Co-Stone Capital, Gaorong Ventures, and Northern Light Venture Capital are 5 of 35 investors who have invested in Inno Medicine.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
